Company Filing History:
1 out of 54 
1 out of 5,072 
1 out of 1,743 
Years Active: 2020
Title: Samia Martin: Innovator in Viral Infection Research
Introduction
Samia Martin is a prominent inventor based in Savigny sur Orge, France. She has made significant contributions to the field of viral infection research, particularly through her innovative work on peptides. Her research focuses on enhancing the efficiency of viral transduction into target cells, which has important implications for gene therapy and other medical applications.
Latest Patents
Samia Martin holds a patent for "Peptides with viral infection enhancing properties and their use." This invention relates to LAH4 peptides and their functional derivatives, which are designed to improve the transduction efficiency of viruses into target cells. This patent highlights her expertise in the intersection of virology and peptide technology.
Career Highlights
Throughout her career, Samia has worked with notable organizations, including Genethon and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Samia has collaborated with esteemed colleagues such as David Fenard and Antoine Kichler. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Samia Martin is a trailblazer in the field of viral infection research, with a focus on innovative peptide technologies. Her contributions through patents and collaborations continue to advance our understanding of viral transduction and its applications in medicine.